Celyad Oncology SA
F:1C0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celyad Oncology SA
F:1C0
|
BE |
|
J
|
Jollibee Foods Corp
OTC:JBFCY
|
PH |
|
R
|
Ridley Corporation Ltd
F:RI6
|
AU |
|
I
|
Ion Electronic Materials Co Ltd
TPEX:6959
|
TW |
|
C
|
Compagnie d'entreprises CFE SA
SWB:C70
|
BE |
|
Julius Baer Gruppe AG
OTC:JBARF
|
CH |
|
H
|
Huddly AS
OSE:HDLY
|
NO |
|
T
|
Teleservice AG
XMUN:TH51
|
DE |
|
W
|
Wellfield Technologies Inc
OTC:WFLDF
|
CA |
|
S
|
Starr Peak Mining Ltd
XTSX:STE
|
CA |
|
Nippon Sanso Holdings Corp
TSE:4091
|
JP |
|
Grid Battery Metals Inc
XTSX:CELL
|
CA |
|
Af Legal Group Ltd
ASX:AFL
|
AU |
|
T
|
Tamul Multimedia Co Ltd
KOSDAQ:093640
|
KR |
|
K
|
KT Alpha Co Ltd
KOSDAQ:036030
|
KR |
|
NTM GOLD ORD
ASX:NTM
|
AU |
Bankruptcy Probability
Celyad Oncology SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celyad Oncology SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BE |
|
Celyad Oncology SA
XBRU:CYAD
|
9.8m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
471.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
217.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
179B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
74.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celyad Oncology SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celyad Oncology SA has no debt.
You can find a full breakdown on its Balance Sheet.